Liver Diseases  >>  beclabuvir (BMS-791325)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
beclabuvir (BMS-791325) / BMS
RHACE 1, NCT02098616: Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

Completed
N/A
25
US
DCV/ASV/BMS-791325, Fixed Dose Combination (FDC) of Daclatasvir/Asunaprevir/BMS-791325, DCV/ASV/BMS-791325 + RBV
Timothy Morgan, MD, VA Long Beach Healthcare System, National Cancer Institute (NCI), Bristol-Myers Squibb
Hepatitis C
02/16
02/16

Download Options